Anemia of chronic kidney disease and end-stage renal disease: are there unique issues in disadvantaged populations?
Several sources of data indicate that there are racial and ethnic disparities in the management of anemia of chronic kidney disease and end-stage renal disease. In this article, I present evidence documenting these disparities and discuss possible factors that may explain the suboptimal anemia management. I also provide recommendations to improve anemia management in disadvantaged populations.
Obrador
Gregorio T
GT
Universidad Panamericana, School of Medicine, Mexico City, Mexico, USA. gobrador@up.edu.mx
D000740:Anemia / Q000175:diagnosis / Q000188:drug therapy / Q000208:ethnology*; D015897:Comorbidity; D004921:Erythropoietin / Q000627:therapeutic use; D006297:Health Services Accessibility; D054624:Health Status Disparities; D006397:Hematinics / Q000627:therapeutic use; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000208:ethnology* / Q000628:therapy; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis / Q000379:methods; D014481:United States / Q000453:epidemiology; D035862:Vulnerable Populations / Q000208:ethnology*
D006397:Hematinics; D004921:Erythropoietin